Anesthetic Concerns for Esophageal Surgery

  • Jacob JacksonEmail author
  • Alessia Pedoto


Esophageal surgery for cancer can be curative but is associated with significant morbidity and mortality. Scrutinizing the perioperative anesthetic management for the procedure seeks to understand its impact on outcomes and discover opportunities for improvement. Moreover, surgical approaches to esophagectomy continue to evolve with the advent of minimally invasive techniques and robotic surgery, and anesthetic methods and concerns must evolve in parallel.


Esophageal cancer Anesthesia One-lung ventilation Goal directed fluid therapy Thoracic epidural analgesia Enhanced recovery after surgery 


  1. 1.
    Mantziari S, Hübner M, Demartines N, Schäfer M. Impact of preoperative risk factors on morbidity after esophagectomy: is there room for improvement? World J Surg. 2014;38(11):2882–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Eliasen M, Grønkjær M, Skov-Ettrup LS, et al. Preoperative alcohol consumption and postoperative complications: a systematic review and meta-analysis. Ann Surg. 2013;258(6):930–42.CrossRefPubMedGoogle Scholar
  3. 3.
    Yousefzadeh A, Chung F, Wong DT, et al. Smoking cessation: the role of the anesthesiologist. Anesth Analg. 2016;122(5):1311–20.CrossRefPubMedGoogle Scholar
  4. 4.
    Nozoe T, Kimura Y, Ishida M, et al. Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol. 2002;28(4):396–400.CrossRefPubMedGoogle Scholar
  5. 5.
    Yoshida N, Baba Y, Shigaki H, et al. Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2016;40(8):1910–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Burt BM, Groth SS, Sada YH, et al. Utility of adjuvant chemotherapy after neoadjuvant chemoradiation and esophagectomy for esophageal cancer. Ann Surg. 2017;266(2):297–304.CrossRefPubMedGoogle Scholar
  7. 7.
    Klevebro F, Johnsen G, Johnson E, et al. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: a randomized clinical trial neoadjuvant chemotherapy vs. neoadjuvant chemoradiation. Eur J Surg Oncol. 2015;41(7):920–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Dilruba S, Kalayda GV. Platinum-based drugs: past, present and future. Cancer Chemother Pharmacol. 2016;77(6):1103–24.CrossRefPubMedGoogle Scholar
  9. 9.
    Thomas SA, Grami Z, Mehta S, Patel K. Adverse effects of 5-fluorouracil: focus on rare side effects. Cancer Cell Microenviron. 2016;3:e1266.Google Scholar
  10. 10.
    Oh SJ, Han S, Lee W, Lockhart AC. Emerging immunotherapy for the treatment of esophageal cancer. Expert Opin Investig Drugs. 2016;25(6):667–77.CrossRefGoogle Scholar
  11. 11.
    Cukier P, Santini FC, Scaranti M, Hoff AO. Endocrine side effects of cancer immunotherapy. Endocr Relat Cancer. 2017;24(12):T331–47.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014;64(22):e77–e137.CrossRefPubMedCentralPubMedGoogle Scholar
  13. 13.
    Pandey A, Sood A, Sammon JD, et al. Effect of preoperative angina pectoris on cardiac outcomes in patients with previous myocardial infarction undergoing major noncardiac surgery (data from ACS-NSQIP). Am J Cardiol. 2015;115(8):1080–4.CrossRefPubMedCentralPubMedGoogle Scholar
  14. 14.
    McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med. 2004;351(27):2795–804.CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Spahn DR, Howell SJ, Delabays A, Chassot PG. Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth. 2006;96(6):675–7.CrossRefPubMedCentralPubMedGoogle Scholar
  16. 16.
    Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and non-cardiac sugery – a prospective outcome study. Br J Anaesth. 2006;96(6):686–93.CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Voltolini L, Rapicetta C, Luzzi L, et al. Lung resection for non-small cell lung cancer after prophylactic coronary angioplasty and stenting: short- and long-term results. Minerva Chir. 2012;67(1):77–85.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth. 2010;104(3):305–12.CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Banerjee S, Angiolillo DJ, Boden WE, et al. Use of antiplatelet therapy/DAPT for post-PCI patients undergoing noncardiac surgery. J Am Coll Cardiol. 2017;69(14):1861–70.CrossRefPubMedCentralPubMedGoogle Scholar
  20. 20.
    Ward HB, Kelly RF, Thottapurathu L, et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of perioperative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg. 2006;82(3):795–800.CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Yamana I, Takeno S, Hashimoto T, et al. Randomized controlled study to evaluate the efficacy of a preoperative respiratory rehabilitation program to prevent postoperative pulmonary complications after esophagectomy. Dig Surg. 2015;32(5):331–7.CrossRefPubMedCentralPubMedGoogle Scholar
  22. 22.
    Schreurs LMA, Janssens ACJW, Groen H, et al. Value of EUS in determining curative resectability in reference to CT and FDG-PET: the optimal sequence in preoperative staging of esophageal cancer? Ann Surg Oncol. 2016;23(suppl 5):1021–8.CrossRefPubMedCentralPubMedGoogle Scholar
  23. 23.
    Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg. 1998;85(6):840–4.CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    Mcmillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40.CrossRefPubMedCentralPubMedGoogle Scholar
  25. 25.
    Bosch DJ, Pultrum BB, Bock GHD, et al. Comparison of different risk-adjustment models in assessing short-term surgical outcome after transthoracic esophagectomy in patients with esophageal cancer. Am J Surg. 2011;202(3):303–9.CrossRefPubMedCentralPubMedGoogle Scholar
  26. 26.
    Dutta S, Al-Mrabt NM, Fullarton GM, et al. A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection. Ann Surg Oncol. 2011;18(10):2808–17.CrossRefPubMedCentralPubMedGoogle Scholar
  27. 27.
    Smith TB, Stonell C, Purkayastha S, et al. Cardiopulmonary exercise testing as a risk assessment method in non cardio-pulmonary surgery: a systematic review. Anaesthesia. 2009;64(8):883–93.CrossRefPubMedCentralPubMedGoogle Scholar
  28. 28.
    Older P, Smith R, Courtney P, et al. Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest. 1993;104(3):701–4.CrossRefPubMedCentralPubMedGoogle Scholar
  29. 29.
    Forshaw MJ, Strauss DC, Davies AR, et al. Is cardiopulmonary exercise testing a useful test before esophagectomy? Ann Thorac Surg. 2008;85(1):294–9.CrossRefPubMedCentralPubMedGoogle Scholar
  30. 30.
    Moyes L, Mccaffer C, Carter R, et al. Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery. Ann R Coll Surg Engl. 2013;95(2):125–30.CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Turan A, Koyuncu O, Egan C, et al. Effect of various durations of smoking cessation on postoperative outcomes: a retrospective cohort analysis. Eur J Anaesthesiol. 2017;34:1–10.CrossRefGoogle Scholar
  32. 32.
    Yoshida N, Baba Y, Hiyoshi Y, et al. Duration of smoking cessation and postoperative morbidity after esophagectomy for esophageal cancer: how long should patients stop smoking before surgery? World J Surg. 2016;40(1):142–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Dettling DS, Schaaf MVD, Blom RL, et al. Feasibility and effectiveness of pre-operative inspiratory muscle training in patients undergoing oesophagectomy: a pilot study. Physiother Res Int. 2013;18(1):16–26.CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Melis M, Mcloughlin JM, Dean EM, et al. Correlations between neoadjuvant treatment, anemia and perioperative complications in patients undergoing esophagectomy for cancer. J Surg Res. 2009;153(1):114–20.CrossRefPubMedGoogle Scholar
  35. 35.
    Muñoz M, García-Erce JA, Cuenca J, et al. On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery. Blood Transfus. 2012;10(1):8–22.PubMedPubMedCentralGoogle Scholar
  36. 36.
    Findlay JM, Gillies RS, Millo J, et al. Enhanced recovery for esophagectomy: a systematic review and evidence-based guidelines. Ann Surg. 2014;259(3):413–31.CrossRefPubMedGoogle Scholar
  37. 37.
    Li L, Wang Z, Ying X, et al. Preoperative carbohydrate loading for elective surgery: a systematic review and meta-analysis. Surg Today. 2012;42(7):613–24.CrossRefPubMedGoogle Scholar
  38. 38.
    Yuill KA, Richardson RA, Davidson HI, et al. The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively – a randomised clinical trial. Clin Nutr. 2005;24(1):32–7.CrossRefPubMedGoogle Scholar
  39. 39.
    Jenkins TK, Lopez AN, Sarosi GA, et al. Preoperative enteral access is not necessary prior to multimodality treatment of esophageal cancer. Surgery. 2018;163(4):770–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Sihag S, Kosinski AS, Gaissert HA, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from the Society of Thoracic Surgeons National Database. Ann Thorac Surg. 2016;101(4):1281–8.CrossRefPubMedCentralPubMedGoogle Scholar
  41. 41.
    Luketich JD, Pennathur A, Awais O, et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg. 2012;256(1):95–103.CrossRefPubMedCentralPubMedGoogle Scholar
  42. 42.
    Luketich JD, Pennathur A, Franchetti Y, et al. Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg. 2015;261(4):702–7.CrossRefPubMedCentralPubMedGoogle Scholar
  43. 43.
    Biere SS, Cuesta MA, van der Peet DL. Minimally invasive versus open esophagectomy for cancer: a systematic review and meta-analysis. Minerva Chir. 2009;64(2):121–33.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Palanivelu C, Prakash A, Senthilkumar R, et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position – experience of 130 patients. J Am Coll Surg. 2006;203(1):7–16.CrossRefPubMedGoogle Scholar
  45. 45.
    Rucklidge M, Sanders D, Martin A. Anaesthesia for minimally invasive oesophagectomy. Contin Educ Anaesth Crit Care Pain. 2010;10(2):43–7.CrossRefGoogle Scholar
  46. 46.
    Narayanaswamy M, McRae K, Slinger P, et al. Choosing a lung isolation device for thoracic surgery: a randomized trial of three bronchial blockers versus double-lumen tubes. Anesth Analg. 2009;108(4):1097–101.CrossRefPubMedGoogle Scholar
  47. 47.
    Yamakazi T, Ohsumi H. The airway scope is a practical intubation device for a double-lumen tube during rapid-sequence induction. J Cardiothorac Vasc Anesth. 2009;23(6):926.Google Scholar
  48. 48.
    Molena D, Mungo B, Stern M, et al. Incidence and risk factors for respiratory complications in patients undergoing esophagectomy for malignancy: a NSQIP analysis. Semin Thorac Cardiovasc Surg. 2014;26(4):287–94.CrossRefPubMedGoogle Scholar
  49. 49.
    Shen Y, Zhong M, Wu W, et al. The impact of tidal volume on pulmonary complications following minimally invasive esophagectomy: a randomized and controlled study. J Thorac Cardiovasc Surg. 2013;146(5):1267–73.CrossRefPubMedGoogle Scholar
  50. 50.
    Lohser J, Slinger P. Lung injury after one-lung ventilation: a review of the pathophysiologic mechanisms affecting the ventilated and the collapsed lung. Anesth Analg. 2015;121(2):302–18.CrossRefPubMedCentralPubMedGoogle Scholar
  51. 51.
    Rudin A, Flisberg P, Johansson J, et al. Thoracic epidural analgesia or intravenous morphine analgesia after thoracoabdominal esophagectomy: a prospective follow-up of 201 patients. J Cardiothorac Vasc Anesth. 2005;19(3):350–7.CrossRefPubMedCentralPubMedGoogle Scholar
  52. 52.
    Flisberg P, Törnebrandt K, Walther B, et al. Pain relief after esophagectomy: thoracic epidural analgesia is better than parenteral opioids. J Cardiothorac Vasc Anesth. 2001;15(3):282–7.CrossRefPubMedCentralPubMedGoogle Scholar
  53. 53.
    Bong CL, Samuel M, Ng JM, et al. Effects of preemptive epidural analgesia on post-thoracotomy pain. J Cardiothorac Vasc Anesth. 2005;19(6):786–93.CrossRefPubMedCentralPubMedGoogle Scholar
  54. 54.
    Wei L, Yongchun L, Qingyuan H, et al. Short and long-term outcomes of epidural or intravenous analgesia after esophagectomy: a propensity-matched cohort study. PLoS One. 2016;11(4):e0154380.CrossRefGoogle Scholar
  55. 55.
    Davies RG, Myles PS, Graham JM. A comparison of the analgesic efficacy and side-effects of paravertebral vs epidural blockade for thoracotomy – a systematic review and meta-analysis of randomized trials. Br J Anaesth. 2006;96(4):418–26.CrossRefPubMedCentralPubMedGoogle Scholar
  56. 56.
    Blanco R, Parras T, McDonnell JG, Prats-Galino A. Serratus plane block: a novel ultrasound-guided thoracic wall nerve block. Anesthesia. 2013;68(11):1107–13.CrossRefGoogle Scholar
  57. 57.
    Forero M, Adhikary SD, Lopez H, et al. The erector spinae plane block: a novel analgesic technique in thoracic neuropathic pain. Reg Anesth Pain Med. 2016;41(5):621–7.CrossRefPubMedCentralPubMedGoogle Scholar
  58. 58.
    Gorissen KJ, Benning D, Berghmans T, et al. Risk of anastomotic leakage with non-steroidal anti-inflammatory drugs in colorectal surgery. Br J Surg. 2012;99(5):721–7.CrossRefPubMedCentralPubMedGoogle Scholar
  59. 59.
    Rushfeldt CF, Sveinbjørnsson B, Søreide K, Vonen B. Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery. Int J Color Dis. 2011;26(12):1501–9.CrossRefGoogle Scholar
  60. 60.
    Cavalcante AN, Sprung J, Schroeder DR, Weingarten TN. Multimodal analgesic therapy with gabapentin and its association with postoperative respiratory depression. Anesth Analg. 2017;125(1):141–6.CrossRefPubMedCentralPubMedGoogle Scholar
  61. 61.
    Navarro LH, Bloomstone JA, Auler JO Jr, et al. Perioperative fluid therapy: a statement from the international Fluid Optimization Group. Perioper Med (Lond). 2015;4:3.CrossRefGoogle Scholar
  62. 62.
    Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth. 2002;89(4):622–32.CrossRefPubMedCentralPubMedGoogle Scholar
  63. 63.
    Durkin C, Schisler T, Lohser J. Current trends in anesthesia for esophagectomy. Curr Opin Anaesthesiol. 2017;30(1):30–5.PubMedPubMedCentralGoogle Scholar
  64. 64.
    Veelo DP, van Berge Henegouwen MI, Ouwehand KS, et al. Effect of goal-directed therapy on outcome after esophageal surgery: a quality improvement study. PLoS One. 2017;12(3):e0172806.CrossRefPubMedCentralPubMedGoogle Scholar
  65. 65.
    Klijn E, Niehof S, de Jonge J, et al. The effect of perfusion pressure on gastric tissue blood flow in an experimental gastric tube model. Anesth Analg. 2010;110(2):541–6.CrossRefPubMedCentralPubMedGoogle Scholar
  66. 66.
    Pathak D, Pennefather SH, Russell GN, et al. Phenylephrine infusion improves blood flow to the stomach during oesophagectomy in the presence of a thoracic epidural analgesia. Eur J Cardiothorac Surg. 2013;44(1):130–3.CrossRefPubMedCentralPubMedGoogle Scholar
  67. 67.
    Ambrus R, Achiam MP, Secher NH, et al. Evaluation of gastric microcirculation by laser speckle contrast imaging during esophagectomy. J Am Coll Surg. 2017;225(3):395–402.CrossRefPubMedCentralPubMedGoogle Scholar
  68. 68.
    Ohi M, Toiyama Y, Mohri Y, et al. Prevalence of anastomotic leak and the impact of indocyanine green fluorescein imaging for evaluating blood flow in the gastric conduit following esophageal cancer surgery. Esophagus. 2017;14(4):351–9.CrossRefPubMedCentralPubMedGoogle Scholar
  69. 69.
    McCulloch P, Ward J, Tekkis PP, et al. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ. 2003;327(7425):1192–7.CrossRefPubMedCentralPubMedGoogle Scholar
  70. 70.
    Tandon S, Batchelor A, Bullock R, et al. Peri-operative risk factors for acute lung injury after elective oesophagectomy. Br J Anaesth. 2001;86(5):633–8.CrossRefPubMedGoogle Scholar
  71. 71.
    McKevith JM, Pennefather SH. Respiratory complications after oesophageal surgery. Curr Opin Anaesthesiol. 2010;23(1):34–40.CrossRefPubMedGoogle Scholar
  72. 72.
    Chebbout R, Heywood EG, Drake TM, et al. A systematic review of the incidence of and risk factors for postoperative atrial fibrillation following general surgery. Anaesthesia. 2018;73(4):490–8.CrossRefPubMedGoogle Scholar
  73. 73.
    Amar D, Burt ME, Bains MS, Leung DH. Symptomatic tachydysrhythmias after esophagectomy: incidence and outcome measures. Ann Thorac Surg. 1996;61(5):1506–9.CrossRefPubMedGoogle Scholar
  74. 74.
    Amar D. Postoperative atrial fibrillation: is there a need for prevention? J Thorac Cardiovasc Surg. 2016;151(4):913–5.CrossRefPubMedGoogle Scholar
  75. 75.
    Carney A, Dickinson M. Anesthesia for esophagectomy. Anesthesiol Clin. 2015;33(1):143–63.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Anesthesiology and Critical Care MedicineMemorial Sloan Kettering Cancer CenterNew YorkUSA

Personalised recommendations